Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]
Leave a Reply
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]
Leave a Reply
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]
